Sign inJoin waitlistJoin the waitlist

Nikolaos Trikalinos

Physician · Washington University School of Medicine

Credentials: · · · · · · ·

History

Washington University School of Medicine
Present

Hematology and Medical Oncology
2008–2011
Internal Medicine
MetroWest Medical Center-Framingham Union Hospital
2005–2008
UNIV OF IOANNINA, IOANNINA, GREECE
2001–2005

Research

Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 538 citations
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018
Journal of the National Comprehensive Cancer Network · 2018 · 284 citations
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
New England Journal of Medicine · 2025 · 127 citations

Deyali Chatterjee
10 papers
Manik Amin
9 papers
BT
Benjamin Tan
7 papers
CH
Chet Hammill
7 papers
RS
Rama Suresh
7 papers
Vikas Prasad
6 papers
Andrea Wang-Gillam
5 papers
HP
Haeseong Park
5 papers
KP
Katrina Pedersen
5 papers
William Hawkins
5 papers
JS
Jonathan Strosberg
4 papers
KL
Kian-Huat Lim
4 papers

Clinical trials

Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)
Principal investigator · Recruiting · Phase 2
Washington University School of Medicine
2025–2034
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Principal investigator · Recruiting · Phase 1
National Cancer Institute (NCI)
2024–2026
Cabozantinib in High Grade Neuroendocrine Neoplasms
Principal investigator · Active not recruiting · Phase 2
Washington University School of Medicine
2020–2027
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2029